NASDAQ · Biotechnology

HCWB (HCWB) Stock

$2.65 +6.00% NASDAQ: HCWB Healthcare

Valuation

MetricValue
Price$2.65
Market Cap$921249
P/E Ratio-0.23
P/B Ratio1.69
P/S Ratio0.77
EPS (TTM)$-10.63
52-Week High$7.35
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-266.67%
ROA-32.00%
ROCE-366.67%
Gross Margin99.24%
Operating Margin-97.88%
Net Margin-24.73%
Debt/Equity1.14
Current Ratio0.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$7.0M$3.0M$3.0M$0
Operating Profit$-13.0M$-15.0M$-26.0M$-29.0M$-11.0M
Net Profit$-13.0M$-15.0M$-25.0M$-30.0M$-8.0M
EPS$-0.36$-0.42$-0.70$-0.77$-10.63
Op Margin—-224.3%-905.0%-1148.5%-20757.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$47.0M$29.0M$30.0M$25.0M
Total Liabilities$2.0M$9.0M$15.0M$37.0M$22.0M
Cash$12.0M$22.0M$4.0M$5.0M$2.0M
Borrowings$0$6.0M$6.0M$14.0M$7.0M

Latest News

HCW Biologics to Implement 1-for-6 Reverse Stock Split MT Newswires · Jun 30, 2026 HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter GlobeNewswire · Jun 30, 2026 HCW Biologics Board Approves 1-for-6 Reverse Stock Split MT Newswires · Jun 26, 2026 HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 GlobeNewswire · Jun 26, 2026 HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata GlobeNewswire · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-10.0M$-23.0M$-14.0M$-13.0M
Investing Cash Flow$-35.0M$4.0M$-2.0M$-1.0M$0
Financing Cash Flow$-7.0M$0$0$2.0M$-1.0M
Net Cash Flow$3.0M$11.0M$-19.0M$1.0M$-3.0M
Free Cash Flow$-11.0M$-21.0M$-29.0M$-14.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-225.96%
Quick Ratio0.09
Interest Coverage-11.00
Return 1Y-83.56%
Return 3Y-99.15%
Return 5Y—

Ownership

Insiders Held9.24%
Institutions Held8.59%
Institutions Float Held9.47%
Institutional HolderSharesReport Date
HRT Financial LP44,3992026-03-31
Virtu Financial LLC7,9682026-03-31
Geode Capital Management, LLC5,9812026-03-31
Citadel Advisors Llc4,3472026-03-31
Tower Research Capital LLC (TRC)2,4742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About HCWB

HCWB is led by CEO Hing C. Wong, employs 36 people, headquartered in US, publicly traded since 2021.

HCWB stock trades at $2.65 with a market capitalization of $921249. The stock is valued at a price-to-earnings (P/E) ratio of -0.23, price-to-book of 1.69, price-to-sales of 0.77. Over the past 52 weeks the stock has ranged between $0.25 and $7.35, and currently trades 63.9% below its 52-week high.

On profitability, HCWB generates a return on equity (ROE) of -266.67%, return on capital employed of -366.67%, an operating margin of -97.88%, a net profit margin of -24.73%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides